Investec Bank Plc has filed a Form 8.5 public dealing disclosure relating to Advanced Medical Solutions Group Plc, in its capacity as an exempt principal trader.
The disclosure, filed on 20th October 2026, covers dealings undertaken by Investec on 19th October 2026 in the ordinary shares of Advanced Medical Solutions Group Plc.
Investec Bank Plc holds a recognised intermediary status and was acting in a client-serving capacity when the reported transactions were carried out.
The bank serves as Advisor and Joint Broker to Advanced Medical Solutions Group Plc, establishing its connection to the offer party named in the disclosure.
According to the filing, Investec purchased 11,365 ordinary shares at a price of 282.25 pence per unit on the dealing date in question.
In addition to the purchases, the bank also sold 4,143 ordinary shares at a price of 282.5 pence per unit during the same dealing session.
No cash-settled derivative transactions were reported in the filing, and no stock-settled derivative transactions or options were disclosed either.
Investec confirmed there are no indemnity or option arrangements, or any agreements or understandings relating to relevant securities, that may constitute an inducement to deal or refrain from dealing.
Similarly, the bank reported no agreements or understandings relating to voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced.
The disclosure was made in accordance with Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status.
The contact named in the filing is Gary Darch, reachable by telephone at 0207 597 4549, for any queries relating to the disclosure content.
Public disclosures under Rule 8 of the Takeover Code are required to be made to a Regulatory Information Service, ensuring transparency in dealings during offer periods.
